MRK Insider Trading

Insider Ownership Percentage: 0.09%
Insider Buying (Last 12 Months): $250,012.25
Insider Selling (Last 12 Months): $209,562.36

Merck & Co., Inc. Insider Trading History Chart

This chart shows the insider buying and selling history at Merck & Co., Inc. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$250kbought$210ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M-$50M$0$50M$100MTotal Insider BuyingTotal Insider Selling

Merck & Co., Inc. Share Price & Price History

Current Price: $88.06
Price Change: Price Increase of +0.188 (0.21%)
As of 03/26/2025 04:59 PM ET

This chart shows the closing price history over time for MRK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$87.88Closing price on 03/25/25:

SEC Filings (Institutional Ownership Changes) for Merck & Co., Inc. (NYSE:MRK)

76.07% of Merck & Co., Inc. stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MRK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$12Bbought$8.33BsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100B$0$100BTotal InflowsTotal Outflows
Merck & Co., Inc. logo
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More on Merck & Co., Inc.

Today's Range

Now: $88.06
Low: $87.31
High: $89.32

50 Day Range

MA: $92.60
Low: $83.01
High: $100.72

52 Week Range

Now: $88.06
Low: $81.04
High: $134.63

Volume

13,807,591 shs

Average Volume

10,310,121 shs

Market Capitalization

$222.44 billion

P/E Ratio

13.08

Dividend Yield

3.42%

Beta

0.35

Who are the company insiders with the largest holdings of Merck & Co., Inc.?

Merck & Co., Inc.'s top insider shareholders include:
  1. Robert M Davis (CEO)
  2. Richard R Deluca (EVP)
  3. Rita A Karachun (VP)
  4. Steven Mizell (EVP)
  5. Joseph Romanelli (Insider)
  6. Johannes Jacobus Oosthuizen (Insider)
  7. Cristal N Downing (Insider)
  8. Inge G Thulin (Director)
  9. Sanat Chattopadhyay (Insider)
Learn More about top insider investors at Merck & Co., Inc..

Who are the major institutional investors of Merck & Co., Inc.?

Merck & Co., Inc.'s top institutional shareholders include:
  1. Vanguard Group Inc. — 9.93%
  2. Wellington Management Group LLP — 3.20%
  3. Geode Capital Management LLC — 2.42%
  4. FMR LLC — 1.48%
  5. Norges Bank — 1.38%
  6. Northern Trust Corp — 1.24%
Learn More about top institutional investors of Merck & Co., Inc. stock.

Which institutional investors are selling Merck & Co., Inc. stock?

During the previous quarter, MRK stock was sold by these institutional investors:
  1. FMR LLC
  2. Price T Rowe Associates Inc. MD
  3. Capital World Investors
  4. Amundi
  5. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main
  6. Legal & General Group Plc
  7. Ameriprise Financial Inc.
  8. International Assets Investment Management LLC

Which institutional investors are buying Merck & Co., Inc. stock?

During the last quarter, MRK stock was acquired by institutional investors including:
  1. Norges Bank
  2. Bank of New York Mellon Corp
  3. Wellington Management Group LLP
  4. Northern Trust Corp
  5. Dimensional Fund Advisors LP
  6. Franklin Resources Inc.
  7. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. Invesco Ltd.
Within the previous year, these company insiders have bought Merck & Co., Inc. stock:
  1. Robert M Davis (CEO)
  2. Richard R Deluca (EVP)
Learn More investors buying Merck & Co., Inc. stock.